Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

【24h】

Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

机译：早期雌激素受体（ER）阳性乳腺癌血管内异质性评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：早期雌激素受体（ER）阳性乳腺癌血管内异质性评估
2. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. [J] . Bartlett JM, Ellis IO, Dowsett M, Journal of Clinical Oncology . 2007,第28期

机译：人表皮生长因子受体2的状态与雌激素受体（ER）阴性的患者的淋巴结受累有关，但与ER阳性的早期乳腺癌患者的分级有关，适用于细胞毒性化学疗法。
3. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk [J] . Kim Jin You, Kim Jin Joo, Hwangbo Lee, European radiology . 2020,第1期

机译：雌激素受体阳性，HER2阴性，节点阴性乳腺癌的扩散加权MRI：腹腔内异质性和复发风险之间的关联
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay [O] . Shinobu Masuda, Hiroaki Nitta, Brian D. Kelly, -1

机译：用明田多重测定评估人表皮生长因子受体2阳性乳腺癌中表达的肿瘤雌激素受体异质性
7. Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay [O] . Shinobu Masuda, Hiroaki Nitta, Brian D. Kelly, 2019

机译：用明田多重测定评估人表皮生长因子受体2阳性乳腺癌中表达的肿瘤雌激素受体异质性
8. Multi-Domain Assembly of Nuclear Estrogen Receptors: Structural Insights into ER-Positive Breast Cancer Therapeutics. [R] . G. Greene 2013

机译：核雌激素受体的多域组装：ER阳性乳腺癌治疗的结构见解。

Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

著录项

相似文献

相关主题

期刊订阅